These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 530102)

  • 1. Susceptibility of Ad12-transformed S (+) and S (-) mouse cells to cell-mediated immunity in vitro.
    Maeta Y; Hamada C
    Microbiol Immunol; 1979; 23(11):1085-95. PubMed ID: 530102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association of virus-specific cell surface and H-2 antigens in Ad12-infected and -transformed mouse cells.
    Maeta Y; Hamada C
    Microbiol Immunol; 1981; 25(2):137-54. PubMed ID: 7231218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cells working for rejection of Ad12 tumors in mice.
    Maeta Y; Toshima M; Miura R; Yamai TY; Hamada C
    Microbiol Immunol; 1982; 26(12):1139-48. PubMed ID: 6302452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus type 12 specific cell surface antigen in transformed cells is a product of the E1b early region.
    Föhring B; Gallimore PH; Mellow GH; Raska K
    Virology; 1983 Dec; 131(2):463-72. PubMed ID: 6197809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of induction of cell-mediated immunity to virus infections: in vitro inhibition of intracellular multiplication of mouse adenovirus by immune spleen cells.
    Hamada C; Uetake H
    Infect Immun; 1975 May; 11(5):937-43. PubMed ID: 164414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.
    Soddu S; Lewis AM
    J Virol; 1992 May; 66(5):2875-84. PubMed ID: 1313906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region E1a of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis.
    Kenyon DJ; Raska K
    Virology; 1986 Dec; 155(2):644-54. PubMed ID: 2947382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma.
    Eager KB; Williams J; Breiding D; Pan S; Knowles B; Appella E; Ricciardi RP
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5525-9. PubMed ID: 3927302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of tumorigenic phenotypes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions.
    Lewis AM; Cook JL
    Cancer Res; 1982 Mar; 42(3):939-44. PubMed ID: 6277479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity assayed by 51Cr release test in mice infected with mouse adenovirus.
    Inada T; Uetake H
    Infect Immun; 1978 Apr; 20(1):1-5. PubMed ID: 208968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S
    Int J Cancer; 1983 Jun; 31(6):785-90. PubMed ID: 6190766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific transplantation and surface antigen in cells transformed by the adenovirus 12 DNA fragments.
    Shiroki K; Shimojo H; Maeta Y; Hamada C
    Virology; 1979 Nov; 99(1):188-91. PubMed ID: 494494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.
    Rotem-Yehudar R; Winograd S; Sela S; Coligan JE; Ehrlich R
    J Exp Med; 1994 Aug; 180(2):477-88. PubMed ID: 7519239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity of adenovirus-transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells.
    Sawada Y; Föhring B; Shenk TE; Raska K
    Virology; 1985 Dec; 147(2):413-21. PubMed ID: 3878030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to mouse adenovirus infection. Blocking of macrophage migration inhibition and T cell-mediated cytolysis of infected cells by anti-S antigen or anti-alloantigen serum.
    Inada T; Uetake H
    Microbiol Immunol; 1980; 24(6):525-35. PubMed ID: 6968021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular protein differences between nontumorigenic Ad5 and tumorigenic Ad12 transformed mouse cells.
    Eager KB; Sawicki JA; Ricciardi RP
    Virology; 1986 Jul; 152(2):487-91. PubMed ID: 3727404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.